PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) | MicrobiomeTrials← Back to trialsNCT07169630
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2029-04-11
Enrollment target: 90 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Aging
Background:
Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other…
Baltimore, United StatesEst. completion Dec 12, 2029
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2Alzheimer Disease 3Alzheimer Disease, Early OnsetAlzheimer Disease, Late OnsetAlzheimer Disease 9Alzheimer Disease 4Alzheimer Disease 7Alzheimer Disease 17
Alzheimer's Dementia Late Onset
Alzheimer Disease 5
Alzheimer Disease 6
Alzheimer Disease 8
Alzheimer Disease 10
Alzheimer Disease 11
Alzheimer Disease 12
Alzheimer Disease 13
Alzheimer Disease 14
Alzheimer Disease 15
Alzheimer Disease 16
Alzheimer Disease 18
Alzheimer Disease 19
Dementia
Dementia Alzheimers
Dementia, Mild
Dementia of Alzheimer Type
Dementia Moderate
Dementia Senile
Mild Cognitive Impairment
Mild Dementia
MCI
Cognitive Impairment
Cognitive Decline
Cognitive Impairment, Mild
This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to modera…
Gilbert, United StatesCompleted Jun 22, 2026